Sequential or concomitant application of PI3K isoform signal targeted therapies enhances cell death by preventing their cross-redundancy in pancreatic ductal adenocarcinoma.
Journal article published in 2017 by
Julie Guillermet-Guibert,
Célia Cintas 
,
Thibaut Douche,
Nicole Therville,
Romain Baer,
Dantes Zahra,
Barbara Garmy-Susini,
Céline Basset,
Max Reichert
,
Thibaut Douche,
Nicole Therville,
Romain Baer,
Dantes Zahra,
Barbara Garmy-Susini,
Céline Basset,
Max Reichert
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 